21st Nov 2012 14:30
Transaction by Person Discharging Managerial Responsibilities
Disclosure Rule DTR 3.1.4
On 20 November 2012, Pascal Soriot, a Director of the Company notified us that, on 20 November 2012, he purchased 3,500 AstraZeneca PLC Ordinary Shares of $0.25 each at a price of 2825 pence per share.
Under the Company's Articles of Association, by way of qualification, a Director is required to be the beneficial owner of 500 Ordinary Shares of the Company, such shares to be obtained within two months of the date of his appointment.
Following this purchase, Mr Soriot has a total interest, including the previously disclosed interest under certain of the Company's share plans, in 141,716 AstraZeneca shares.
A C N Kemp
Company Secretary
21 November 2012
Related Shares:
Astrazeneca